Your browser doesn't support javascript.
loading
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis.
Shafagati, Nazila; Koh, Min J; Boussi, Leora; Park, Hyun J; Stuver, Robert; Bain, Paul; Foss, Francine M; Shen, Changyu; Jain, Salvia.
Afiliación
  • Shafagati N; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
  • Koh MJ; School of Medicine, Georgetown University, Washington, DC.
  • Boussi L; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
  • Park HJ; Dartmouth School of Medicine, Dartmouth, NH.
  • Stuver R; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Bain P; Harvard Medical School, Harvard University, Boston, MA.
  • Foss FM; Department of Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, CT.
  • Shen C; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
  • Jain S; Biogen, Cambridge, MA.
Blood Adv ; 6(16): 4740-4762, 2022 08 23.
Article en En | MEDLINE | ID: mdl-35816645
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células T Periférico / Recurrencia Local de Neoplasia Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células T Periférico / Recurrencia Local de Neoplasia Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Marruecos